ScoreWhy is Panacea Biotec Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate -250.53% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -8.48
2
Flat results in Dec 25
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 81.61 cr
- NON-OPERATING INCOME(Q) is 61.29 % of Profit Before Tax (PBT)
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -27.11%, its profits have fallen by -139.9%
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -2.30% in the last 1 year, its fall in the stock was much higher with a return of -27.11%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Panacea Biotec for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Panacea Biotec
-27.15%
-0.54
50.38%
Sensex
-5.18%
-0.40
13.03%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.80%
EBIT Growth (5y)
-250.53%
EBIT to Interest (avg)
-8.48
Debt to EBITDA (avg)
4.30
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.76
Tax Ratio
32.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.22%
ROCE (avg)
-10.90%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
32
Price to Book Value
2.37
EV to EBIT
-28.03
EV to EBITDA
-55.65
EV to Capital Employed
2.48
EV to Sales
3.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.42%
ROE (Latest)
-5.72%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
PBDIT(Q)
Highest at Rs 11.74 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 7.11%
PBT LESS OI(Q)
Highest at Rs 1.44 cr.
PAT(Q)
Highest at Rs 2.32 cr.
-2What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 81.61 cr
NON-OPERATING INCOME(Q)
is 61.29 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Panacea Biotec
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1.44 cr has Grown at 171.64%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 11.74 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 7.11%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.44 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 2.32 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Panacea Biotec
Non Operating Income - Quarterly
is 61.29 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 81.61 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
